Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171863 | SCV000050879 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000171863 | SCV000581945 | uncertain significance | not provided | 2018-02-08 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the ACTN2 gene. The R482W variant was reported as a variant of uncertain significance in one individual from a cohort of individuals not selected for cardiomyopathy, arrhythmia, or family history of sudden cardiac death, who underwent exome sequencing (Ng et al., 2013). This variant is observed in 9/66,280 (0.01%) alleles from individuals of European (Non-Finnish) ancestry in the Exome Aggregation Consortium (ExAC) dataset (Lek et al., 2016; Exome Variant Server). Nevertheless, the R482W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. |
Labcorp Genetics |
RCV002054030 | SCV002423157 | likely benign | Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000171863 | SCV002541777 | uncertain significance | not provided | 2021-05-20 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000171863 | SCV004238928 | uncertain significance | not provided | 2023-06-16 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000601112 | SCV000734004 | uncertain significance | Dilated cardiomyopathy 1AA | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000171863 | SCV001920211 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000171863 | SCV001930964 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171863 | SCV001955096 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000171863 | SCV001966876 | uncertain significance | not provided | no assertion criteria provided | clinical testing |